|
Back to the Enlightened American
Website |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 Stocks Unanimously Loved By Analysts |
|
|
|
|
|
|
|
|
|
Criteria Used: |
| Morningstar Rating
= 5 stars |
|
|
|
|
|
| 80% of analysts
give highest recommendation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disclaimer: This page lists the
results of a stock screen for informational purposes only. This does not constitute an endorsement
and/or solicitation for the reader to invest in these stocks. Please consult
a qualified financial advisor to determine if these securities are suitable
for your situation. All numbers provided by Reuters and Yahoo Finance and are
not guaranteed to be accurate. Readers are advised to double-check the
numbers for themselves. |
|
|
|
|
|
|
|
|
screen |
|
|
Prices as of |
3/6/2012 |
|
|
|
|
| Ticker |
COMPANY |
Current Price |
52 week range |
Market Cap |
Yield |
PE |
Payout Ratio |
EV / EBITDA |
Debt to EBITDA |
Estimated Intrinsic Value |
FCF on ROA annual avg |
P/FCF annual avg |
Business Description |
|
| F |
Ford Motor Co (F) |
$12.09 |
9.05 - 16.18 |
45.951B |
0.05 (0.40%) ex-div:"Jan
27" |
2.5 |
8% |
10.0 |
8.0 |
$
20.00 |
2.8% |
6.1 |
Ford Motor Company (Ford) is a
producer of cars and trucks. Ford and its subsidiaries are also engaged in
other businesses, including financing vehicles. It operates under two
segments: Automotive and Financial Services. Automotive segment includes the
operations of Ford North America, Ford South America, Ford Europe and Ford...
( Returns vs. Industry: ROE (281.62 : 0.96) ROI (18.41 : 0.38) |
|
| GM |
General Motors Co (GM) |
$24.58 |
19.00 - 33.47 |
38.486B |
N/A |
5.7 |
N/A |
1.7 |
1.1 |
$
- |
-7.1% |
(3.7) |
General Motors Company (GM) is a
global automotive company. It develops, produces and markets cars, trucks and
parts worldwide. GM also provides automotive financing services through
General Motors Financial Company, Inc. (GM Financial), formerly AmeriCredit
Corp. (AmeriCredit). These financing operations consist principally of... (
Returns vs. Industry: ROE (28.35 : 0.96) ROI (6.57 : 0.38) |
|
| HAL |
Halliburton Co (HAL) |
$34.13 |
27.21 - 57.77 |
31.501B |
0.36 (1.03%) ex-div:"Mar 5" |
11.4 |
12% |
5.6 |
0.8 |
$
12.00 |
2.9% |
34.3 |
Halliburton Company is an
oilfield services company. The Company is provider of services and products
to the energy industry related to the exploration, development, and
production of oil and natural gas. It serves national, and independent oil
and natural gas companies worldwide and operates in two segments: Completion
and... ( Returns vs. Industry: ROE (25.50 : 8.57) ROI (17.17 : 6.95) |
|
| NIHD |
NII Holdings Inc (NIHD.O) |
$17.06 |
16.82 - 44.21 |
2.920B |
N/A |
15.0 |
N/A |
3.2 |
3.1 |
$
8.00 |
0.9% |
30.3 |
NII Holdings, Inc. (NII
Holdings) provides wireless communication services under the Nextel brand
through operating companies located in selected Latin American markets, with
its principal operations located in Mexico, Brazil, Argentina, Peru and
Chile. Nextel Direct Connect is a long-range walkie-talkie service for
communicatio... ( Returns vs. Industry: ROE (6.16 : 8.97) ROI (2.81 : 6.61) |
|
| SVNT |
Savient Pharmaceuticals Inc
(SVNT.A) |
$1.86 |
1.84 - 11.91 |
130.9M |
N/A |
N/A |
N/A |
N/A |
N/A |
$
- |
- |
- |
Savient Pharmaceuticals, Inc.
(Savient) is a specialty biopharmaceutical company focused on commercializing
KRYSTEXXA (pegloticase) in the United States and completing the development
and seeking regulatory approval outside of the United States for KRYSTEXXA,
particularly in the European Union. KRYSTEXXA was approved for... ( Returns
vs. Industry: ROE (-562.87 : 7.54) ROI (-67.26 : 5.54) |
|
|
|
|
|
|
| TICKER |
COMPANY |
Current Price |
52 week range |
Market Cap |
Yield |
PE |
Payout Ratio |
EV / EBITDA |
Debt to EBITDA |
Estimated Intrinsic Value |
FCF on ROA annual avg |
P/FCF annual avg |
Business Description |
|
| VNDA |
Vanda Pharmaceuticals Inc
(VNDA.A) |
$4.51 |
4.33 - 8.45 |
126.8M |
N/A |
N/A |
N/A |
N/A |
N/A |
$
- |
- |
- |
Vanda Pharmaceuticals Inc.
(Vanda) is a biopharmaceutical company focused on the development and
commercialization of products for central nervous system disorders. The
Company’s products include Fanapt and Tasimelteon. Fanapt (iloperidone) is
a compound for the treatment of schizophrenia. On October 12, 2009, Vanda
entered into... ( Returns vs. Industry: ROE (-27.53 : 7.54) ROI (-5.89 :
5.54) |
|
| WPX |
WPX Energy Inc (WPX) |
$18.22 |
14.20 - 23.42 |
3.619B |
N/A |
N/A |
N/A |
3.7 |
1.2 |
$
- |
- |
- |
WPX Energy, Inc. (WPX Energy) is
an independent natural gas and oil exploration and production company engaged
in the exploitation and development of long-life unconventional properties.
The Company focuses on exploiting its natural gas reserve base and related
NGLs in the Piceance Basin of the Rocky Mountain region, and on... ( Returns
vs. Industry: ROE (-- : 12.15) ROI (-- : 11.28) |
|
|
|
|
Back
to the Enlightened American Website |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
